MileStone
2020
- We will join with the medical profession to invest in research projects on the immune response to influenza and respiratory viral infections, and strengthen the prevention and treatment of viral threats.
2019
- The Malaysian overseas subsidiary was formally established to expand the Southeast Asian market.
- We will join hands with Taizong Biotech's "Liquid Biopsy" technology to be early diagnose liver cancer tumors and becom pioneer in the liver cancer recurrence detection platform.
- We launched a personalized all-round genetic test and integrate with the "Taiwan Precision Medical Initiative (TPMI)".
2018
- In 2018 first "Personal Genetic Databank" services to five important stage of life as the basis for individuals to create whole genome database.
2015
- The 1st Affymetrix Service Provider certified lab in Taiwan
- The 1st Illumina MiSeq CSPro certified lab in Taiwan
2014
- Granted CAP Accreditation
- Signed Japanese agencies to serve the local market
2013
- Named Deloitte’s 2013 Technology Fast 500 Asia Pacific Companies
- Implemented the 1st Process Management and Compliance (PMC) system for the largest API manufacturer in Taiwan
2012
- Named Deloitte’s 2012 Technology Fast 500 Asia Pacific Companies
- The 1st publicly traded company specializing in genetic diagnosis and scientific informatics in Taiwan with its IPO (4160-TW).
2011
- Winner of the 2011 Corporate Social Responsibility (CSR) Excellence Awards for Taiwanese Small and Medium Enterprises (SMEs)
- Awarded ASSTD (Assist Service Sector Technology Development) grant from Ministry of Economy
- Established Informatics Business Unit
2010
- Winner of the 2010 Promising Enterprise of the Taiwan Healthcare and Agricultural Biotech Industries Innovation and Excellence Awards
- Granted with a Small Business Innovation Research (SBIR) Program from Ministry of Economic Affairs in Taiwan
2009
- The 1st lab to offer PGD service in Taiwan as well as in Asia
2008
- GGA Corp. Founded
